PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA ...

Good morning, and welcome to the Culp conference call to review the company’s results for the first quarter of fiscal 2025.

On Saturday, Jan. 10, the world of running will be descending on Tallahassee for the World Cross Country Championships, ...

But why not self-soothe with IndieWire’s list of the most-anticipated upcoming movies that aren’t “One Battle After Another,” ...

The limited-edition 4K Ultra HD combo ($39.99 retail) includes audio commentaries, retrospective and vintage interviews, ...

Cohere is one of Canada’s most valuable startups at US$7 billion. (Credit: Gabby Jones) Despite the long-standing trend of Canadian founders moving to the United States and declining venture capital ...